Journalartikel

Management of Urosepsis in 2018


AutorenlisteBonkat, Gernot; Cai, Tomasso; Veeratterapillay, Rajan; Bruyere, Franck; Bartoletti, Riccardo; Pilatz, Adrian; Koves, Bela; Geerlings, Suzanne E.; Pradere, Benjamin; Pickard, Robert; Wagenlehner, Florian M. E.

Jahr der Veröffentlichung2019

Seiten5-9

ZeitschriftEuropean Urology Focus

Bandnummer5

Heftnummer1

eISSN2405-4569

DOI Linkhttps://doi.org/10.1016/j.euf.2018.11.003

VerlagElsevier


Abstract

Despite optimal treatment, urosepsis has still high morbidity and mortality rates. An updated definition and classification system for sepsis have recently been introduced. Management of urosepsis comprises four major aspects: (1) early diagnosis, (2) early empiric intravenous antimicrobial treatment, (3) identification and control of complicating factors, and (4) specific sepsis therapy. The quick sequential organ failure assessment is replacing the systemic inflammatory response syndrome scoring for rapid identification of patients with urosepsis.

Patient summary: Urosepsis is a serious, life-threatening complication of infections originating from the urinary tract. As urosepsis has a very high mortality rate, it is important that is quickly spotted and that appropriate treatment is swiftly begun. Imaging of urinary tract disorders has been shown to be useful in decreasing mortality from urosepsis, and in the future microbiology techniques may also prove useful. Given the severity of urosepsis and the associated risks, large efforts need to be made to prevent high-risk infections in hospitals with appropriate prevention measures, such as the early removal of catheters used whenever possible. (c) 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.




Zitierstile

Harvard-ZitierstilBonkat, G., Cai, T., Veeratterapillay, R., Bruyere, F., Bartoletti, R., Pilatz, A., et al. (2019) Management of Urosepsis in 2018, European urology focus, 5(1), pp. 5-9. https://doi.org/10.1016/j.euf.2018.11.003

APA-ZitierstilBonkat, G., Cai, T., Veeratterapillay, R., Bruyere, F., Bartoletti, R., Pilatz, A., Koves, B., Geerlings, S., Pradere, B., Pickard, R., & Wagenlehner, F. (2019). Management of Urosepsis in 2018. European urology focus. 5(1), 5-9. https://doi.org/10.1016/j.euf.2018.11.003



Schlagwörter


ANTIMICROBIAL THERAPYPrevention measuresUrological infectionsUrosepsis


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:24